Skip to main content
Explore URMC
menu

Nab-Paclitaxel in Treating Patients With Newly Diagnosed Bile Tract Cancer

Research Question:
How well does gemcitabine hydrochloride and cisplatin - given with or without nab-paclitaxel - work in treating patients with newly diagnosed biliary tract cancers?

Basic Study Information

Purpose:
This phase III trial studies how well gemcitabine hydrochloride and cisplatin - given with or without nab-paclitaxel - work in treating patients with newly diagnosed biliary tract cancers that have spread to other places in the body. Drugs used in chemotherapy, such as gemcitabine hydrochloride, cisplatin, and nab-paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not known if giving gemcitabine hydrochloride and cisplatin with or without nab-paclitaxel may work better at treating biliary tract cancers.

Location: University of Rochester Medical Center
Study Reference #: CGIH19111

Lead Researcher (Principal Investigator)

Lead Researcher: Aram Hezel

Study Contact Information

Study Coordinator: Chris LeFeber
Phone: (585) 275-0407
Email: Chris_LeFeber@URMC.Rochester.edu

Additional Study Details

Return to Search